Learn more

SUTRO BIOPHARMA INC

Overview
  • Total Patents
    193
  • GoodIP Patent Rank
    9,687
  • Filing trend
    ⇧ 7.0%
About

SUTRO BIOPHARMA INC has a total of 193 patent applications. It increased the IP activity by 7.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are METIS PREC MEDICINE SB S R L, SHATTUCK LABS INC and TRANSTARGET INC.

Patent filings per year

Chart showing SUTRO BIOPHARMA INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Stafford Ryan 78
#2 Thanos Christopher D 67
#3 Yam Alice 66
#4 Yin Gang 49
#5 Gill Avinash 41
#6 Penta Kalyani 37
#7 Li Xiaofan 33
#8 Yang Junhao 33
#9 Sato Aaron 29
#10 Baliga Ramesh 24

Latest patents

Publication Filing date Title
WO2020257235A1 1-(4-(aminomethyl)benzyl)-2-butyl-2h-pyrazolo[3,4-c]quinolin-4-amine derivatives and related compounds as toll-like receptor (tlr) 7/8 agonists, as well as antibody drug conjugates thereof for use in cancer therapy and diagnosis
WO2020252015A1 Immunomodulator antibody drug conjugates and uses thereof
WO2020252043A1 5H-PYRROLO[3,2-d]PYRIMIDINE-2,4-DIAMINO COMPOUNDS AND ANTIBODY CONJUGATES THEREOF
WO2020227105A1 Anti-bcma antibody conjugates
WO2020227110A1 Anti-bcma antibody conjugate, compositions comprising the same, and methods of making and using the same
WO2020097385A1 E coli strains having an oxidative cytoplasm
WO2020060944A1 Combination therapies with anti-folate receptor antibody conjugates
WO2019190969A1 Anti-bcma receptor antibodies, compositions comprising anti bcma receptor antibodies and methods of making and using anti-bcma antibodies
CA3075087A1 Anti- folate receptor alpha antibody conjugates and their uses
WO2019023316A1 Methods of using anti-cd74 antibodies and antibody conjugates in treatment of t-cell lymphoma
WO2018217940A2 Pd-1/lag3 bi-specific antibodies, compositions thereof, and methods of making and using the same
EP3585813A1 Pd-1/tim-3 bi-specific antibodies, compositions thereof, and methods of making and using the same
US2020190192A1 Pd-1/tim-3 bi-specific antibodies, compositions thereof, and methods of making and using the same
WO2018071597A1 Anti-folate receptor antibodies, compositions comprising anti-folate receptor antibodies and methods of making and using anti-folate receptor antibodies
EP3472197A1 Antibodies with engineered ch2 domains, compositions thereof and methods of using the same
SG11201806419RA Anti-cd74 antibody conjugates, compositions comprising anti-cd74 antibody conjugates and methods of using anti-cd74 antibody conjugates
EP3377533A2 Anti-lag3 antibodies, compositions comprising anti-lag3 antibodies and methods of making and using anti-lag3 antibodies
US2018251547A1 Anti-tim-3 antibodies, compositions comprising anti-tim-3 antibodies and methods of making and using anti-tim-3 antibodies
WO2017023704A1 ANTI-EpCAM ANTIBODIES, COMPOSITIONS COMPRISING ANTI-EpCAM ANTIBODIES AND METHODS OF MAKING AND USING ANTI-EpCAM ANTIBODIES
CN107428801A For Hammett woods (hemiasterlin) derivative for being coupled and treating